Geneva, March 20 -- International Clinical Trials Registry received information related to the study (DRKS00039327) titled 'Courses of treatment and determinants in long COVID and other post-viral syndromes' on Feb. 27.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: health services research
Primary Sponsor: aQua - Institut fur angewandte Qualitatsforderung und Forschung im Gesundheitswesen GmbH
Condition:
U09.9
G93.3
Post COVID-19 condition, unspecified
Postviral fatigue syndrome
Intervention:
Group 1: BARMER insured persons with a documented diagnosis of long COVID (ICD-10_GM U09.9) and/or CFS (ICD-10-GM G93.3) are invited to participate in the written survey. To capture a...